Gyre Therapeutics
Stock Forecast, Prediction & Price Target
Gyre Therapeutics Financial Estimates
Gyre Therapeutics Revenue Estimates
Gyre Therapeutics EBITDA Estimates
Gyre Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $7.33M N/A | $794K -89.17% | $113.45M 14188.41% | Avg: $84.81M Low: $84.81M High: $84.81M avg. -25.24% | |||
Net Income
% change YoY
| $-87.93M N/A | $2.30M 102.61% | $-92.93M -4137.05% | Avg: $-19.74M Low: $-19.74M High: $-19.74M avg. 78.74% | |||
EBITDA
% change YoY
| $-87.60M N/A | $-52.15M 40.46% | $20.32M 138.97% | Avg: $-16.96M Low: $-16.96M High: $-16.96M avg. -183.44% | |||
EPS
% change YoY
| -$2.87 N/A | $0.04 101.26% | -$1.41 -3995.02% | Avg: -$0.3 Low: -$0.3 High: -$0.3 avg. 78.72% | |||
Operating Expenses
% change YoY
| $87.85M N/A | $30.40M -65.39% | $176.04M 479.03% | Avg: $456.23M Low: $456.23M High: $456.23M avg. 159.15% | |||
FAQ
What is Gyre Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 78.74% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -19.74M, average is -19.74M and high is -19.74M.
What is Gyre Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -25.24% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $84.81M, average is $84.81M and high is $84.81M.
What is Gyre Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 78.72% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.3, average is -$0.3 and high is $-0.3.